Early response predicts subsequent response to olanzapine long-acting injection in a randomized, double-blind clinical trial of treatment for schizophrenia

被引:0
作者
Haya Ascher-Svanum
Fangyi Zhao
Holland C Detke
Allen W Nyhuis
Anthony H Lawson
Virginia L Stauffer
William Montgomery
Michael M Witte
David P McDonnell
机构
[1] Lilly Corporate Center,Global Health Outcomes, Eli Lilly and Company
[2] Lilly Corporate Center,Psychosis Team, Eli Lilly and Company
[3] Lilly USA LLC,Lilly Neuroscience
[4] Eli Lilly Australia Pty Ltd,undefined
[5] Eli Lilly and Company,undefined
来源
BMC Psychiatry | / 11卷
关键词
Schizophrenia; Olanzapine; Positive Predictive Value; Negative Predictive Value; Early Responder;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 117 条
[1]  
Agid O(2003)Delayed-onset hypothesis of antipsychotic action: a hypothesis tested and rejected Arch Gen Psychiatry 60 1228-1235
[2]  
Kapur S(2005)Evidence for onset of antipsychotic effects within the first 24 hours of treatment Am J Psychiatry 162 939-946
[3]  
Arenovich T(2005)Early-onset hypothesis of antipsychotic drug action: a hypothesis tested, confirmed and extended Biol Psychiatry 57 1543-1549
[4]  
Zipursky RB(2008)Clinical, functional, and economic ramifications of early nonresponse to antipsychotics in the naturalistic treatment of schizophrenia Schizophr Bull 34 1163-1171
[5]  
Kapur S(2003)Early prediction of antipsychotic response in schizophrenia Am J Psychiatry 160 2063-2065
[6]  
Arenovich T(2008)Predicting response to atypical antipsychotics based on early response in the treatment of schizophrenia Schizophr Res 102 230-240
[7]  
Agid O(2010)Early response to antipsychotic drug therapy as a clinical marker of subsequent response in the treatment of schizophrenia Neuropsychopharmacology 35 581-590
[8]  
Zipursky RB(2007)Early prediction of antipsychotic nonresposne among patients with schizophrenia J Clin Psychiatry 68 353-360
[9]  
Lindborg S(1987)The positive and negative syndrome scale (PANSS) for schizophrenia Schizophr Bull 13 261-276
[10]  
Jones B(2008)An 8-week, double-blind, randomized, placebo-controlled study of olanzapine long-acting injection in acutely ill patients with schizophrenia J Clin Psychiatry 69 790-799